These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 27137789)
1. Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Fu N; Wong T Curr Infect Dis Rep; 2016 Jun; 18(6):19. PubMed ID: 27137789 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916 [TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study. Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549 [TBL] [Abstract][Full Text] [Related]
4. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting. Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384 [TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report. Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904 [TBL] [Abstract][Full Text] [Related]
13. Management of inflammatory bowel disease with D'Aoust J; Battat R; Bessissow T World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153 [TBL] [Abstract][Full Text] [Related]
15. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Solanky D; Pardi DS; Loftus EV; Khanna S Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451 [TBL] [Abstract][Full Text] [Related]
16. The interplay of Sehgal K; Yadav D; Khanna S Therap Adv Gastroenterol; 2021; 14():17562848211020285. PubMed ID: 34104215 [TBL] [Abstract][Full Text] [Related]
17. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients. Albarrak AA; Romana BS; Uraz S; Yousef MH; Juboori AA; Tahan V Endocr Metab Immune Disord Drug Targets; 2019; 19(7):929-935. PubMed ID: 30827274 [TBL] [Abstract][Full Text] [Related]
18. Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial. Gawronska A; Banasiuk M; Lachowicz D; Pituch H; Albrecht P; Banaszkiewicz A Inflamm Bowel Dis; 2017 Dec; 23(12):2209-2214. PubMed ID: 29084080 [TBL] [Abstract][Full Text] [Related]